http://orcid.org/0000-0002-4450-2550
About the Authors
- Fernando de Assis Ferreira Melo
-
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: uroacre@hotmail.com
Affiliation Division of Urology, Acre Federal University, Rio Branco, Acre, Brazil
- Etienne Macedo
-
Roles Data curation, Supervision, Writing – original draft, Writing – review & editing
Affiliation Department of Medicine, University of California San Diego (UCSD), San Diego, California, United States of America
- Ana Caroline Fonseca Bezerra
-
Roles Data curation
Affiliation Division of Urology, Acre Federal University, Rio Branco, Acre, Brazil
- Walédya Araújo Lopes de Melo
-
Roles Data curation
Affiliation Division of Urology, Acre Federal University, Rio Branco, Acre, Brazil
- Ravindra L. Mehta
-
Roles Conceptualization, Formal analysis, Writing – review & editing
Affiliation Department of Medicine, University of California San Diego (UCSD), San Diego, California, United States of America
- Emmanuel de Almeida Burdmann
-
Roles Conceptualization, Funding acquisition, Methodology, Supervision, Validation, Visualization, Writing – review & editing
Affiliation LIM 12, Division of Nephrology, University of São Paulo Medical School, São Paulo, São Paulo, Brazil
- Dirce Maria Trevisan Zanetta
-
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Writing – review & editing
Affiliation Department of Epidemiology, University of São Paulo School of Public Health, São Paulo, São Paulo, Brazil
Competing Interests
Professor Ravindra Mehta: RLM reports grants from the International Safety Adverse Events Consortium and Thrasos and has consulting agreements from AbbVie, AM Pharma, Eli Lilly, Ardea, Astute Inc, CSL Behring, GSK and AstraZeneca. Professor Emmanuel Burdmann: EB has consultant agreements from AstraZeneca and Fresenius. This does not alter our adherence to PLOS ONE policies on sharing data and materials.